MyFinsight
Home
Blog
About
Back
Income Statement
AN2 Therapeutics, Inc. (ANTX)
AN2 Therapeutics, Inc. (ANTX)
source: myfinsight.com
Comprehensive loss
-$8.203M
(-26.49%↓ Y/Y)
Net loss
attributable to common...
-$8.185M
(-26.66%↓ Y/Y)
Unrealized loss on
investments
-$0.018M
(21.74%↑ Y/Y)
Interest income
$0.72M
(-4.51%↓ Y/Y)
Loss from operations
-$8.904M
(-23.39%↓ Y/Y)
Other expense
-$0.001M
Total operating
expenses
$8.904M
(23.39%↑ Y/Y)
Research and development
$6.019M
(88.09%↑ Y/Y)
General and
administrative
$2.885M
(-28.16%↓ Y/Y)
Back